At the outset of the initiative, clinical research groups in each partner organisation were asked to identify rare cancers where there was enthusiasm for international collaborations and the potential for development of an interventional (preferably randomised) clinical trial.  Where interests coincided in at least two of the lead organisations, and the IRCI Board could see potential for research development, IRCI groups were formed.The following nine rare cancers were selected and have formed the core activities of IRCI to date.

Rare Cancer Types

Active groups